NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
NeoImmuneTech
Hoffmann-La Roche
Eli Lilly and Company
Hoffmann-La Roche
Fundación GECP
Sumitomo Pharma America, Inc.
Weill Medical College of Cornell University
Hoffmann-La Roche
Revolution Medicines, Inc.
H. Lee Moffitt Cancer Center and Research Institute
University of Washington
Daiichi Sankyo